Literature DB >> 33628531

New-Onset Diabetes in Children during COVID-19: Clinical Case Report.

M Aabdi1, A Aarab2, O Es-Saad1, K Malki1, H Bkiyar1, B Housni1.   

Abstract

INTRODUCTION: Data of COVID-19 in newborns and children are limited, and clinical manifestations are nonspecific and might delay the diagnosis, which might lead to severe complications. In this clinical case, we will describe new-onset diabetes with consciousness impairment as an atypical revealing way of COVID-19. CASE: A 3-year-old child presented to the Emergency Department with loss of consciousness (without fever), lethargy, and stupor. Clinical assessment on admission found an unconscious child with a pediatric Glasgow Coma Scale of 10/15 with no localizing signs or meningeal syndrome, polypneic of 35 breaths/min, pulse oximetry of 90%, with signs of overall dehydration: skin folds, sunken eyes, tachycardia of 160 beats/minute, and recoloring time superior at 3 seconds. Laboratory findings showed hyperleukocytosis of 16000/mm3, lymphopenia of 450/mm3, glycemia of 5 g/L with a correct ionogram : corrected natremia of 139 mmol/L, serum potassium of 4.5 mmol/L, glycosuria of 3+, ketonuria of 2+, and HbA1c of 10%, and COVID-19 RT-PCR came back positive.
CONCLUSION: COVID-19 might be revealed with atypical symptoms including new-onset diabetes and diabetic ketoacidosis; therefore, clinicians must suspect it in children with blood glucose and HbA1c at the time of admission. This will help to manage patients with hyperglycemia early.
Copyright © 2021 M. Aabdi et al.

Entities:  

Year:  2021        PMID: 33628531      PMCID: PMC7879331          DOI: 10.1155/2021/6654019

Source DB:  PubMed          Journal:  Case Rep Endocrinol        ISSN: 2090-651X


  17 in total

1.  New-Onset Type 1 Diabetes in Children During COVID-19: Multicenter Regional Findings in the U.K.

Authors:  Rebecca Unsworth; Susan Wallace; Nick S Oliver; Shunmay Yeung; Archana Kshirsagar; Harshini Naidu; Ruth Min Wai Kwong; Priya Kumar; Karen M Logan
Journal:  Diabetes Care       Date:  2020-08-17       Impact factor: 19.112

2.  Epidemiology of COVID-19 Among Children in China.

Authors:  Yuanyuan Dong; Xi Mo; Yabin Hu; Xin Qi; Fan Jiang; Zhongyi Jiang; Shilu Tong
Journal:  Pediatrics       Date:  2020-03-16       Impact factor: 7.124

Review 3.  COVID-19 in people with diabetes: understanding the reasons for worse outcomes.

Authors:  Matteo Apicella; Maria Cristina Campopiano; Michele Mantuano; Laura Mazoni; Alberto Coppelli; Stefano Del Prato
Journal:  Lancet Diabetes Endocrinol       Date:  2020-07-17       Impact factor: 32.069

4.  Newly diagnosed diabetes in COVID-19 patients.

Authors:  Thirunavukkarasu Sathish; Yingting Cao; Nitin Kapoor
Journal:  Prim Care Diabetes       Date:  2020-08-27       Impact factor: 2.459

5.  New-Onset Diabetes in Covid-19.

Authors:  Francesco Rubino; Stephanie A Amiel; Paul Zimmet; George Alberti; Stefan Bornstein; Robert H Eckel; Geltrude Mingrone; Bernhard Boehm; Mark E Cooper; Zhonglin Chai; Stefano Del Prato; Linong Ji; David Hopkins; William H Herman; Kamlesh Khunti; Jean-Claude Mbanya; Eric Renard
Journal:  N Engl J Med       Date:  2020-06-12       Impact factor: 91.245

6.  Diabetes is a risk factor for the progression and prognosis of COVID-19.

Authors:  Weina Guo; Mingyue Li; Yalan Dong; Haifeng Zhou; Zili Zhang; Chunxia Tian; Renjie Qin; Haijun Wang; Yin Shen; Keye Du; Lei Zhao; Heng Fan; Shanshan Luo; Desheng Hu
Journal:  Diabetes Metab Res Rev       Date:  2020-03-31       Impact factor: 4.876

7.  Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes.

Authors:  Jin-Kui Yang; Shan-Shan Lin; Xiu-Juan Ji; Li-Min Guo
Journal:  Acta Diabetol       Date:  2009-03-31       Impact factor: 4.280

8.  Diabetic ketoacidosis precipitated by Covid-19 in a patient with newly diagnosed diabetes mellitus.

Authors:  Ying Jie Chee; Shereen Jia Huey Ng; Ester Yeoh
Journal:  Diabetes Res Clin Pract       Date:  2020-04-24       Impact factor: 5.602

Review 9.  Practical recommendations for the management of diabetes in patients with COVID-19.

Authors:  Stefan R Bornstein; Francesco Rubino; Kamlesh Khunti; Geltrude Mingrone; David Hopkins; Andreas L Birkenfeld; Bernhard Boehm; Stephanie Amiel; Richard Ig Holt; Jay S Skyler; J Hans DeVries; Eric Renard; Robert H Eckel; Paul Zimmet; Kurt George Alberti; Josep Vidal; Bruno Geloneze; Juliana C Chan; Linong Ji; Barbara Ludwig
Journal:  Lancet Diabetes Endocrinol       Date:  2020-04-23       Impact factor: 32.069

Review 10.  COVID-19 epidemic: Disease characteristics in children.

Authors:  Jiatong She; Lanqin Liu; Wenjun Liu
Journal:  J Med Virol       Date:  2020-04-15       Impact factor: 20.693

View more
  4 in total

Review 1.  Diabetes and SARS-CoV-2-Is There a Mutual Connection?

Authors:  Anna P Jedrzejak; Edyta K Urbaniak; Jadwiga A Wasko; Natalia Ziojla; Malgorzata Borowiak
Journal:  Front Cell Dev Biol       Date:  2022-06-13

2.  Epidemiological and Clinical Characteristics of Hospitalized Pediatric Patients with SARS-CoV-2 Infection in Mexico City, Mexico.

Authors:  Gustavo Esteban Lugo-Zamudio; Antonio Aguilar-Rojas; Martín Uriel Vázquez-Medina; Antonio Gutiérrez-Ramírez; Ma Cristina Upton-Alvarado; Patricia Espinoza-Rivas; Gustavo Lagunas-Torres; María Isabel Rojo-Gutiérrez; Gabriela Ibáñez-Cervantes; Cruz Vargas-De-León
Journal:  Can J Infect Dis Med Microbiol       Date:  2022-04-25       Impact factor: 2.585

Review 3.  The global impact of COVID-19 pandemic on the incidence of pediatric new-onset type 1 diabetes and ketoacidosis: A systematic review and meta-analysis.

Authors:  Masoud Rahmati; Maryam Keshvari; Shahrzad Mirnasuri; Dong K Yon; Seung W Lee; Jae Il Shin; Lee Smith
Journal:  J Med Virol       Date:  2022-07-22       Impact factor: 20.693

4.  Guillan barre syndrome in post Covid-19 infection in children.

Authors:  Sanae El Mezzeoui; Fatima Zahra Aftiss; Mohammed Aabdi; Houssam Bkiyar; Brahim Housni
Journal:  Ann Med Surg (Lond)       Date:  2021-06-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.